Features | Partner Sites | Information | LinkXpress
Sign In
RANDOX LABORATORIES
FOCUS DIAGNOSTICS, INC.
GLOBETECH PUBLISHING LLC

Test Aids Diagnosis of Preeclampsia

By Labmedica International staff writers
Posted on 09 Jan 2012
Image: The Alere Triage MeterPro (Photo courtesy of Alere).
Image: The Alere Triage MeterPro (Photo courtesy of Alere).
A test with high sensitivity and specificity level helps diagnosis of early onset preeclampsia.

The triage placental growth factor (PLGF) test is a fluorescence immunoassay, which, when used in conjunction with a Triage Meter enables the quantitative determination of PLGF in ethylenediaminetetraacetic acid (EDTA) anticoagulated plasma samples. Together with other diagnostic and clinical information, the test aids in the diagnosis of preeclampsia.

The Alere (Linz, Austria) Triage PLGF test can provide a PLGF level from a maternal plasma specimen in just 15 minutes. The Triage MeterPro is a portable fluorescence instrument used to measure the results of the Triage tests from Alere. The Triage MeterPro can be used in a laboratory or in a point-of-care setting. It uses a Class 1 laser as a light source. Light from the laser hits a test device that has been inserted in the meter. This causes the fluorescent dye in the test device to give off energy. The more energy the fluorescent dye gives off, the stronger the signal.

The current criteria for defining preeclampsia (raised blood pressure and protein in urine) are nonspecific, appear late in the development of the disease, and result in over-diagnosis because of their poor specificity.

The Lancet online December 15, 2011 published an editorial that highlights the fact that many maternal deaths in the UK are associated with substandard care and are potentially preventable. The article suggests that it is the failure to diagnose or appropriately manage preeclampsia, which is the most common cause of maternal death.

Preeclampsia is a serious and potentially fatal condition that arises in pregnancy, usually in the second or third trimester. The exact cause is unknown but it is thought to be related to a problem with the placenta. The nonspecificity of signs and symptoms contribute to making clinical diagnosis a significant challenge, this represents a high risk to both mother and child.

Prof. Christopher Redman, emeritus professor of Obstetrics at John Radcliffe Hospital (Oxford, United Kingdom) commented, “A reliable and specific test that aids in the diagnosis of those aspects of the preeclampsia syndrome that jeopardize the safety of mother and/or unborn baby would be invaluable. Alere Triage PLGF is a major advance in the assessment for preterm disease.”

Related Links:
Alere
John Radcliffe Hospital



KARL HECHT GMBH & CO KG
CELLAVISION AB
MEDLAB Asia

Channels

Genetic Tests

view channel
Image: For each chromosome, key SNPs are displayed above the chromosome and non-key SNPs below the chromosome, enabling users to determine the accuracy of haploblock calling. SNPs failed to be called are displayed as white points in the middle of the chromosome (Photo courtesy of Illumina).

Karyomapping Proposed as Alternative to Preimplantation Genetic Diagnosis for Evaluation of IVF Embryos

British researchers have suggested that karyomapping is a viable and cost-effective method for detecting a wide range of genetic diseases in IVF (in vitro fertilization) embryos. Preimplantation Genetic... Read more

Industry News

view channel
Image: Positive case of lung tissue stained for ALK with VENTANA ALK (D5F3) CDx Assay, a companion diagnostic immunohistochemical test in the final stages of the FDA premarket approval process (Photo courtesy of Ventana Medical Systems and PRNewsFoto).

Premarket Approval Sought for CDx Test to Benefit Lung Cancer Patients

Ventana Medical Systems, Inc. (Tucson, AZ, USA) has announced its US Food & Drug Administration (FDA) final stage submission for premarket approval (PMA) of its companion diagnostic (CDx) immunohistochemistry... Read more
 

Events

05 Mar 2015 - 08 Mar 2015
18 Mar 2015 - 20 Mar 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.